“…In 2010, we proposed an asymmetric formal synthesis of (−)-platensimycin 25 (Beaulieu et al, 2010 , 2011 ), a natural antibiotic isolated from a strain of Streptomyces platensis by Wang and Soisson in 2006 and acting as a FabF inhibitor (Wang et al, 2006 ). The intriguing structure and bioactivity of this compound have evoked a great deal of interest in the synthetic arena (Nicolaou et al, 2006 , 2007a , b , 2008 , 2009a ; Lalic and Corey, 2007 ; Li et al, 2007 ; Tiefenbacher and Mulzer, 2007 , 2008 ; Zou et al, 2007 ; Kim et al, 2008 ; Matsuo et al, 2008 ; Ghosh and Xi, 2009 ; McGrath et al, 2009 ; Yun et al, 2009 ; Eey and Lear, 2010 , 2014 ; Palanichamy and Kaliappan, 2010 ; Tiefenbacher et al, 2010 ; Xing et al, 2010 ; Hirai and Nakada, 2011 ; Ueda et al, 2011 ; Zheng et al, 2011 ; Horii et al, 2013 ). As illustrated in Figure 4 , we targeted structure 24 , an advanced intermediate in Nicolaou's synthesis (Nicolaou et al, 2009b ) containing the main tetracyclic core of (−)-platensimycin.…”